ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, proprietary novel ...
Legend Biotech stock target cut to $91 by Jefferies
Jefferies maintained its Buy rating on Legend Biotech Corp . (NASDAQ:LEGN) but reduced the stock's price target from $94.00 to $91.00. The adjustment follows reports of Johnson & Johnson's $334 ...
Jefferies maintains Praxis stock with $305 target, bullish on catalysts
Jefferies reaffirmed its positive stance on Praxis Precision Medicines Inc . (NASDAQ:PRAX), maintaining a Buy rating and a price target of $305.00. The stock, currently valued at $1.54 billion market ...
bovnews13m
Why Did Zoom Communications Inc (ZM) Stock See 11.88% Surge in the Last 90 Days?
Zoom Communications Inc (ZM) stock saw a modest uptick, ending the day at $78.54 which represents a slight increase of $0.47 or 0.60% from the prior close of $78.07. The stock opened at $78.79 and ...